Business Context and Reporting Period
This Form 8-K Current Report was filed by DaVita Inc. on October 4, 2012. The filing addresses corporate governance changes and executive appointments related to the pending Merger Agreement between DaVita, Seismic Acquisition LLC, and HealthCare Partners Holdings, LLC (HCP). The Board of Directors voted to increase its size from nine to ten members and appointed Dr. Robert Margolis to fill the new vacancy and serve as Co-Chairman, effective upon the closing of the Merger, which is expected in the fourth quarter of 2012.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics for DaVita Inc. or HCP. The document focuses exclusively on governance and compensation terms.
- Executive Compensation: Dr. Margolis will receive an annual base salary of $600,000.
- Bonus Structure: Eligible for annual performance bonuses for 2012, 2013, and 2014 equal to 40% of base salary, with an additional potential bonus of up to 170% of that amount.
- Severance: In the event of termination without cause, Dr. Margolis is entitled to two times his annual base salary plus a pro-rated prior year performance bonus, paid over 24 months.
- Insurance Costs: Run-off liability insurance premiums are capped at $275,000 for HCP. If total premiums exceed $550,000, HCP bears $275,000 and DaVita bears the remainder.
Material Changes
The primary material change is the restructuring of the Board of Directors and executive leadership in anticipation of the Merger:
- Board size increased from nine to ten members.
- Dr. Robert Margolis appointed as a new Director and member of the Clinical Performance Committee.
- Dr. Margolis appointed as Co-Chairman of the Board, serving alongside current Chairman Mr. Kent Thiry.
- Execution of a new two-year employment agreement for Dr. Margolis, superseding his current HCP agreement.
Guidance, Outlook, and Risks
Outlook: The parties still expect the Merger to close in the fourth quarter of 2012. Dr. Margolis will continue to serve as CEO of HCP post-merger.
Risks and Contingencies: The filing includes forward-looking statements subject to risks that could cause actual results to differ materially, including:
- Costs related to the Merger.
- Inability to satisfy conditions of the Merger.
- Need for outside financing to pay cash consideration.
- Inability to amend senior secured credit facilities or obtain necessary financing.
Unusual Items: The filing details specific run-off insurance arrangements for directors' and officers' liability and employment practices liability, with a six-year term effective at the time of the Merger.
Investor Verification Checklist
- Verify the status of the Merger Agreement and the expected closing date in Q4 2012.
- Review the Prospectus filed September 27, 2012, for details on DaVita Common Stock issuable in the Merger.
- Confirm DaVita's ability to secure financing or amend credit facilities to pay the cash consideration for the Merger.
- Monitor the execution of the amended and restated employment agreement for Dr. Margolis prior to the Merger closing.
- Check for updates on the total cost of the run-off liability insurance policies.